Prosecution Insights
Last updated: October 04, 2026
Application No. 17/967,293

METHODS AND SYSTEMS FOR NON-INVASIVE FORECASTING, DETECTION AND MONITORING OF VIRAL INFECTIONS

Non-Final OA §101
Filed
Oct 17, 2022
Priority
Apr 17, 2020 — provisional 63/011,833 +1 more
Examiner
HOUGH, JESSANDRA F
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Empatica Srl
OA Round
3 (Non-Final)
46%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
81%
With Interview

Examiner Intelligence

Grants 46% of resolved cases
46%
Career Allowance Rate
139 granted / 305 resolved
-24.4% vs TC avg
Strong +36% interview lift
Without
With
+35.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 11m
Avg Prosecution
37 currently pending
Career history
349
Total Applications
across all art units

Statute-Specific Performance

§101
10.2%
-29.8% vs TC avg
§103
51.9%
+11.9% vs TC avg
§102
13.4%
-26.6% vs TC avg
§112
20.6%
-19.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 305 resolved cases

Office Action

§101
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on July 13, 2026 has been entered. Response to Amendment This office action is responsive to the amendment filed on July 13, 2026. As directed by the amendment: claim(s) 1, 13-16, 18, and 24 have been amended, claim(s) 6 and 11-12 have been cancelled, and no claim(s) have been added. Thus, claims 1-5, 7-10, and 13-30 are currently pending in the application. Response to Arguments Applicant's arguments filed July 13, 2026 have been fully considered but they are not persuasive. The applicant principally argues that the claims have been amended in order to overcome the previous 35 U.S.C. 101 rejection of the claims. The examiner respectfully disagrees. The applicant first argues that the claims herein are not directed to a judicial exception because the contain recitations that cannot practically be performed in the human mind. However, the newly added limitations not only appear to be a mental process but also a mathematical operation/process in order to process data. The applicant cites to the August and December Memorandums in light of Ex Parte Desjardins; however, the claims as presented still generically direct the user to utilize a generic model to analyze calibration data which while tedious can be conducted by utilizing pen and paper (as the claims do not require this to be done in a certain time frame) and/or merely appears to be utilizing a processor to automate a mathematical process. Additionally, the newly added limitations are still directed to either an additional element of “alerting” or “making a judgment/mathematical processing” regarding the presented data indicating that the patient is infected are both still abstract ideas without significantly more. Furthermore, the instant invention fails to disclose a specific improvement, as it just details how the data is processed but there are not additional elements which provide a technological improvement. “A claim that recites an abstract idea must include ‘additional features’ to ensure ‘that the [claim] is more than a drafting effort designed to monopolize the [abstract idea]” (quoting Mayo, 566 U.S. at 77). It is important to note, the judicial exception alone cannot provide the improvement. As written, it appears that the applicant’s calculations and data analysis, i.e. the mental process alone, that provide the improvement. Please refer to MPEP 2106.05a. Lastly, the applicant argues that the claims as written provide an improvement to the technology or technical field, by reducing the duration and severity of illness and thereby improve patient outcomes. However, it appears that the implementation of this method via computer elements is the technological improvement, the examiner would like to note that per the MPEP that is not sufficient. “To show that the involvement of a computer assists in improving the technology, the claims must recite the details regarding how a computer aids the method, the extent to which the computer aids the method, or the significance of a computer to the performance of the method. Merely adding generic computer components to perform the method is not sufficient. Thus, the claim must include more than mere instructions to perform the method on a generic component or machinery to qualify as an improvement to an existing technology.” Please refer to MPEP 2106.05(a). Therefore, the examiner is not convinced and the 35 U.S.C. 101 rejection is maintained with the newly added limitations addressed below. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-5, 7-10, and 13-30 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a process (claims 1-5, 7-10, and 13-23) and machine (claims 24-30) (Step 1). Claims 1-5, 7-10, and 13-30 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a judicial exception (i.e., a law of nature, a natural phenomenon, or an abstract idea) without significantly more. In accordance with MPEP 2106.04, each of Claims 1-5, 7-10, and 13-30 has been analyzed to determine whether it is directed to any judicial exceptions. Step 2A, Prong 1 per MPEP 2106.04(a) Each of Claims 1-5, 7-10, and 13-30 recites at least one step or instruction for processing data, which is grouped as a mental process in MPEP 2106.04(a)(2)(III) or a certain method of organizing human activity in MPEP 2106.04(a)(2)(II) or mathematical concept in MPEP 2106.04(a)(2)(I).Accordingly, each of Claims 1-5, 7-10, and 13-30 recites an abstract idea. Specifically, Claim 1 recites: A method, comprising: receiving, from one or more sensors, physiological data of a patient measured by the one or more sensors, the physiological data including movement data associated with the patient; (additional element) identifying a resting time period during which the patient is at rest based on the movement data; (observation, judgment or evaluation, which is grouped as a mental process in MPEP 2106.04(a)(2)(III)) extracting, from the physiological data, data of a set of physiological parameters during a portion of the resting time period; (observation, judgment or evaluation, which is grouped as a mental process in MPEP 2106.04(a)(2)(III)) receiving at least one of demographic data or medical data of the patient; (observation, judgment or evaluation, which is grouped as a mental process in MPEP 2106.04(a)(2)(III)) adjusting the data of the set of physiological parameters extracted during the portion of the resting time period based on the at least one of the demographic data of the medical data; (observation, judgment or evaluation, which is grouped as a mental process in MPEP 2106.04(a)(2)(III)) determining, after adjusting the data of the set of physiological parameters, a derived measure for each physiological parameter from the set of physiological parameters based on the data of the set of physiological parameters extracted during the portion of the resting time period; (observation, judgment or evaluation, which is grouped as a mental process in MPEP 2106.04(a)(2)(III)) adjusting the derived measure for each physiological parameter from the set of physiological parameters based on a baseline measure for the corresponding physiological parameter from the set of physiological parameters to produce a set of adjusted measures, the baseline measure associated with physiological data of the patient collected during a time period prior to the resting time period; (observation, judgment or evaluation, which is grouped as a mental process in MPEP 2106.04(a)(2)(III)) mapping, using a model, the set of adjusted measures to a feature space and determining a location for the set of adjusted measures relative to a boundary in the feature space determined by separating a first set of calibration data points associated with normal data and a second set of calibration data points associated with infected data (observation, judgment or evaluation, which is grouped as a mental process in MPEP 2106.04(a)(2)(III) and/or mathematical relationships, mathematical formulas or equations, mathematical calculations (see MPEP 2106.04(a)(2)(I)))and determining an infection state of the patient based on the location relative to the boundary; (observation, judgment or evaluation, which is grouped as a mental process in MPEP 2106.04(a)(2)(III)) and in response to the infection state of the patient indicating that the patient is infected, generating an alert indicating that the patient is infected prior to the patient exhibiting symptoms of infection. (additional element) Similarly, Independent Claim 24 recites An apparatus, comprising: a memory; (additional element) and a processor operatively coupled to the memory and a set of sensors; the processor configured to execute instructions stored in the memory to: (additional element) receive, from the set of sensors, physiological data of a patient measured by the set of sensors; (additional element) extract, from the physiological data, data of a set of physiological parameters during a resting time period associated with the patient; (observation, judgment or evaluation, which is grouped as a mental process in MPEP 2106.04(a)(2)(III)). determine a derived measure for each physiological parameter from the set of physiological parameters based on the data of the set of physiological parameters extracted during the resting time period; (observation, judgment or evaluation, which is grouped as a mental process in MPEP 2106.04(a)(2)(III)). adjust the derived measure for each physiological parameter from the set of physiological parameters based on a baseline measure for the corresponding physiological parameter from the set of physiological parameters to produce a set of adjusted measures, the baseline measure associated with physiological data of the patient collected during a time period prior to the resting time period; (observation, judgment or evaluation, which is grouped as a mental process in MPEP 2106.04(a)(2)(III)). determine a predictive value indicative of an infection level of the patient using a model for predicting an infection risk of the patient and the set of adjusted measures; and (observation, judgment or evaluation, which is grouped as a mental process in MPEP 2106.04(a)(2)(III)). determine whether the predictive value is greater than a predefined threshold value, wherein the predefined threshold value is adjustable to modify a sensitivity for determining an infection state of the patient; (observation, judgment or evaluation, which is grouped as a mental process in MPEP 2106.04(a)(2)(III)); in response to the predictive value being greater than the predefined threshold value, determine that the patient is infected; (observation, judgment or evaluation, which is grouped as a mental process in MPEP 2106.04(a)(2)(III) and/or mathematical relationships, mathematical formulas or equations, mathematical calculations (see MPEP 2106.04(a)(2)(I))); and in response to determining that the patient is infected, generate an alert indicating that the patient is infected prior to the patient exhibiting symptoms of infection. (additional element) Further, dependent Claims 2-5, 7-10, 13-23 and 25-30 merely include limitations that either further define the abstract idea (and thus don’t make the abstract idea any less abstract) or amount to no more than generally linking the use of the abstract idea to a particular technological environment or field of use because they’re merely incidental or token additions to the claims that do not alter or affect how the claimed functions/steps are performed. Accordingly, as indicated above, each of the above-identified claims recites an abstract idea as in MPEP 2106.04(a). Step 2A, Prong 2 per MPEP 2106.04(d) The above-identified abstract idea in each of independent Claims 1 and 24 (and their respective dependent Claims 2-5, 7-10, 13-23 and 25-30) is not integrated into a practical application under MPEP 2106.04(d) because the additional elements (identified above in independent Claims 1 and 24), either alone or in combination, generally link the use of the above-identified abstract idea to a particular technological environment or field of use according to MPEP 2106.05(h) or represent insignificant extra-solution activity according to MPEP 2106.05(g). More specifically, the additional elements of: memory, processor, sensors and alerts are generically recited computer elements in independent Claim 1 and 24 (and their respective dependent claims) which do not improve the functioning of a computer, or any other technology or technical field according to MPEP 2106.04(d)(1) and 2106.05(a). Nor do these above-identified additional elements serve to apply the above-identified abstract idea with, or by use of, a particular machine according to MPEP 2106.05(b), effect a transformation according to MPEP 2106.05(c), provide a particular treatment or prophylaxis according to MPEP 2106.04(d)(2) or apply or use the above-identified abstract idea in some other meaningful way beyond generally linking the use thereof to a particular technological environment, such that the claim as a whole is more than a drafting effort designed to monopolize the exception according to MPEP 2106.04(d)(2) and 2106.05(e). Furthermore, the above-identified additional elements do not add a meaningful limitation to the abstract idea because they amount to simply implementing the abstract idea on a computer in accordance with MPEP 2106.05(f). For at least these reasons, the abstract idea identified above in independent Claims 1 and 24 (and their respective dependent claims) is not integrated into a practical application in accordance with MPEP 2106.04(d). Moreover, the above-identified abstract idea is not integrated into a practical application in accordance with MPEP 2106.04(d) because the claimed method and system merely implements the above-identified abstract idea (e.g., mental process and certain method of organizing human activity) using rules (e.g., computer instructions) executed by a computer (e.g. processor and memory as claimed). In other words, these claims are merely directed to an abstract idea with additional generic computer elements which do not add a meaningful limitation to the abstract idea because they amount to simply implementing the abstract idea on a computer according to MPEP 2106.05(f). Additionally, Applicant’s specification does not include any discussion of how the claimed invention provides a technical improvement realized by these claims over the prior art or any explanation of a technical problem having an unconventional technical solution that is expressed in these claims according to MPEP 2106.05(a). That is, like Affinity Labs of Tex. v. DirecTV, LLC, the specification fails to provide sufficient details regarding the manner in which the claimed invention accomplishes any technical improvement or solution. Thus, for these additional reasons, the abstract idea identified above in independent Claims 1 and 24 (and their respective dependent claims) is not integrated into a practical application under MPEP 2106.04(d)(I). Accordingly, independent Claims 1 and 24 (and their respective dependent claims) are each directed to an abstract idea according to MPEP 2106.04(d). Step 2B per MPEP 2106.05 None of Claims 1-5, 7-10, and 13-30 include additional elements that are sufficient to amount to significantly more than the abstract idea in accordance with MPEP 2106.05 for at least the following reasons. These claims require the additional elements of: memory, processor, sensors and alerts. The above-identified additional elements are generically claimed computer components which enable the above-identified abstract idea(s) to be conducted by performing the basic functions of automating mental tasks. The courts have recognized such computer functions as well understood, routine, and conventional functions when claimed in a merely generic manner (e.g., at a high level of generality) or as insignificant extra-solution activity. See, MPEP 2106.05(d)(II) along with Versata Dev. Group, Inc. v. SAP Am., Inc., 793 F.3d 1306, 1334, 115 USPQ2d 1681, 1701 (Fed. Cir. 2015); and OIP Techs., 788 F.3d at 1363, 115 USPQ2d at 1092-93. Per applicant’s specification, [0045] and [0048] describes the memory and processor with a high level of generality and as a commercially available product. Per applicant’s specification, in [0038] and [0044] describes sensors with a high level of generality and as a commercially available product (e.g. accelerometer, cardiac sensor, optical sensor, ECG sensor, and etc.). Lastly, the instant specification details in [0064] that the alerts can be provided via telephone call, email, text message, push notification on a mobile device, web portal and the like which are generic and commercially available products. Accordingly, in light of Applicant’s specification, the claimed term processor is reasonably construed as a generic computing device. Like SAP America vs Investpic, LLC (Federal Circuit 2018), it is clear, from the claims themselves and the specification, that these limitations require no improved computer resources, just already available technology, with their already available basic functions, to use as tools in executing the claimed process. See MPEP 2106.05(f). Furthermore, Applicant’s specification does not describe any special programming or algorithms required for the processor. This lack of disclosure is acceptable under 35 U.S.C. §112(a) since this hardware performs non-specialized functions known by those of ordinary skill in the computer arts. By omitting any specialized programming or algorithms, Applicant's specification essentially admits that this hardware is conventional and performs well understood, routine and conventional activities in the computer industry or arts. In other words, Applicant’s specification demonstrates the well-understood, routine, conventional nature of the above-identified additional elements because it describes these additional elements in a manner that indicates that the additional elements are sufficiently well-known that the specification does not need to describe the particulars of such additional elements to satisfy 35 U.S.C. § 112(a) (see MPEP 2106.05(d)(I)(2) and 2106.07(a)(III)). Adding hardware that performs “‘well understood, routine, conventional activit[ies]’ previously known to the industry” will not make claims patent-eligible (TLI Communications along with MPEP 2106.05(d)(I)). The recitation of the above-identified additional limitations in Claims 2-5, 7-10, 13-23 and 25-30 amounts to mere instructions to implement the abstract idea on a computer. Simply using a computer or other machinery in its ordinary capacity for economic or other tasks (e.g., to receive, store, or transmit data) or simply adding a general-purpose computer or computer components after the fact to an abstract idea (e.g., a fundamental economic practice or mathematical equation) does not provide significantly more. See MPEP 2106.05(f) along with Affinity Labs v. DirecTV, 838 F.3d 1253, 1262, 120 USPQ2d 1201, 1207 (Fed. Cir. 2016) (cellular telephone); and TLI Communications LLC v. AV Auto, LLC, 823 F.3d 607, 613, 118 USPQ2d 1744, 1748 (Fed. Cir. 2016) (computer server and telephone unit). Moreover, implementing an abstract idea on a generic computer, does not add significantly more, similar to how the recitation of the computer in the claim in Alice amounted to mere instructions to apply the abstract idea of intermediated settlement on a generic computer. A claim that purports to improve computer capabilities or to improve an existing technology may provide significantly more. See MPEP 2106.05(a) along with McRO, Inc. v. Bandai Namco Games Am. Inc., 837 F.3d 1299, 1314-15, 120 USPQ2d 1091, 1101-02 (Fed. Cir. 2016); and Enfish, LLC v. Microsoft Corp., 822 F.3d 1327, 1335-36, 118 USPQ2d 1684, 1688-89 (Fed. Cir. 2016). However, a technical explanation as to how to implement the invention should be present in the specification for any assertion that the invention improves upon conventional functioning of a computer, or upon conventional technology or technological processes. That is, per MPEP 2106.05(a), the disclosure must provide sufficient details such that one of ordinary skill in the art would recognize the claimed invention as providing an improvement. Here, Applicant’s specification does not include any discussion of how the claimed invention provides a technical improvement realized by these claims over the prior art or any explanation of a technical problem having an unconventional technical solution that is expressed in these claims. Instead, as in Affinity Labs of Tex. v. DirecTV, LLC 838 F.3d 1253, 1263-64, 120 USPQ2d 1201, 1207-08 (Fed. Cir. 2016), the specification fails to provide sufficient details regarding the manner in which the claimed invention accomplishes any technical improvement or solution. For at least the above reasons, the apparatuses and methods of Claims 2-5, 7-10, 13-23 and 25-30 are directed to applying an abstract idea as identified above on a general purpose computer without (i) improving the performance of the computer itself or providing a technical solution to a problem in a technical field according to MPEP 2106.05(a), or (ii) providing meaningful limitations to transform the abstract idea into a patent eligible application of the abstract idea such that these claims amount to significantly more than the abstract idea itself according to MPEP 2106.04(d)(2) and 2106.05(e). Taking the additional elements individually and in combination, the additional elements do not provide significantly more. Specifically, when viewed individually, the above-identified additional elements in independent 1 and 24 (and their dependent claims) do not add significantly more because they are simply an attempt to limit the abstract idea to a particular technological environment according to MPEP 2106.05(h). When viewed as a combination, these above-identified additional elements simply instruct the practitioner to implement the claimed functions with well-understood, routine and conventional activity specified at a high level of generality in a particular technological environment according to MPEP 2106.05(h). When viewed as whole, the above-identified additional elements do not provide meaningful limitations to transform the abstract idea into a patent eligible application of the abstract idea such that the claims amount to significantly more than the abstract idea itself according to MPEP 2106.04(d)(2) and 2106.05(e). Moreover, neither the general computer elements nor any other additional element adds meaningful limitations to the abstract idea because these additional elements represent insignificant extra-solution activity according to MPEP 2106.05(g). As such, there is no inventive concept sufficient to transform the claimed subject matter into a patent-eligible application as required by MPEP 2106.05. Therefore, for at least the above reasons, none of the Claims 2-5, 7-10, 13-23 and 25-30 amounts to significantly more than the abstract idea itself. Accordingly, Claims 2-5, 7-10, 13-23 and 25-30 are not patent eligible and rejected under 35 U.S.C. 101. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JESSANDRA F HOUGH whose telephone number is (571)270-7902. The examiner can normally be reached Monday-Thursday 7 am - 4 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at (571)270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Jessandra Hough August 8, 2026 /J.F.H./Examiner, Art Unit 3796 /William J Levicky/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Oct 17, 2022
Application Filed
Jul 01, 2025
Non-Final Rejection mailed — §101
Oct 01, 2025
Response Filed
Feb 12, 2026
Final Rejection mailed — §101
Jul 13, 2026
Request for Continued Examination
Jul 20, 2026
Response after Non-Final Action
Aug 19, 2026
Non-Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746405
Reducing Electrosensation Whilst Treating A Subject Using Alternating Electric Fields
4y 0m to grant Granted Sep 29, 2026
Patent 12702822
PARA-AORTIC BLOOD PUMP DEVICE
4y 5m to grant Granted Aug 11, 2026
Patent 12697166
APPARATUS, SYSTEMS, AND METHODS FOR IDENTIFYING INSTRUMENTS IN LAPAROSCOPIC AND OTHER MINIMALLY INVASIVE SURGERY
7y 0m to grant Granted Aug 04, 2026
Patent 12691298
PHOTOTHERAPY DEVICES FOR TREATMENT OF DERMATOLOGICAL DISORDERS OF THE SCALP
4y 2m to grant Granted Jul 28, 2026
Patent 12678617
NEURAL SLEEVE FOR NEUROMUSCULAR STIMULATION, SENSING AND RECORDING
3y 10m to grant Granted Jul 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
46%
Grant Probability
81%
With Interview (+35.8%)
3y 11m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 305 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month